0000000000409137

AUTHOR

Mónica Gorbe

showing 7 related works from this author

Synthesis and In Vitro Evaluation of a Photosensitizer-BODIPY Derivative for Potential Photodynamic Therapy Applications

2015

A new photosensitizer (1) based on the 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) scaffold has been synthesized. 1 is water soluble and showed an intense absorption band at 490 nm (e=77600 cm-1M-1) and an emission at 514 nm. In vitro toxicity of 1 in the presence of light and in darkness has been studied with HeLa, HaCaT, MCF-7, and SCC-13 cell lines. Moreover, internalization studies of 1 in these cell lines were also performed. These results suggested that 1 is more toxic for SCC-13 and HeLa carcinoma cells than for the HaCaT noncancerous immortal human keratinocytes. Toxicity upon light irradiation was due to the formation of singlet oxygen and reactive oxygen species (ROS). Cel…

Boron CompoundsLightmedicine.medical_treatmentBodipyPhotodynamic therapyPhotochemistrysensorsBiochemistryHeLachemistry.chemical_compoundQUIMICA ORGANICACell Line TumormedicineBIOQUIMICA Y BIOLOGIA MOLECULARHumansPhotosensitizerchemistry.chemical_classificationReactive oxygen speciesPhotosensitizing AgentsphotochemistryMolecular StructureSinglet OxygenbiologySinglet oxygenEndoplasmic reticulumOrganic ChemistryQUIMICA INORGANICAGeneral Chemistrybiology.organism_classificationHaCaTPhotochemotherapychemistryphotodynamic therapyfluorescenceBODIPYReactive Oxygen Species
researchProduct

Halogen-containing BODIPY derivatives for photodynamic therapy

2019

Abstract Two iodinated (1 and 2) and two brominated (3 and 4) BODIPY-based photosensitizers are prepared and characterized using slightly modified synthetic procedures previously described. 1–4 present intense absorption bands in the 510–540 nm interval and very weak emissions due to the presence of halogen atoms in their structure. Irradiation of aqueous solutions of 1–4 with visible light (wavelength > 475 nm) induce the generation of singlet oxygen with quantum yields of ca. 0.62–0.66 for the photosensitizers containing iodine atoms (1 and 2) and of ca. 0.16–0.21 for the brominated counterparts (3 and 4). In vitro studies carried out with HeLa, SCC-13 and HaCaT cell lines and the four ph…

Aqueous solutionbiologySinglet oxygenProcess Chemistry and TechnologyGeneral Chemical Engineeringmedicine.medical_treatmentPhotodynamic therapy02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnologybiology.organism_classificationPhotochemistry01 natural sciences0104 chemical sciencesHeLachemistry.chemical_compoundHaCaTchemistryHalogenmedicineBODIPY0210 nano-technologyVisible spectrumDyes and Pigments
researchProduct

Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells

2015

In recent years, mesoporous silica nanoparticles (MSNs) have been used as effective supports for the development of controlled-release nanodevices that are able to act as multifunctional delivery platforms for the encapsulation of therapeutic agents, enhancing their bioavailability and overcoming common issues such as poor water solubility and poor stability of some drugs. In particular, redox-responsive delivery systems have attracted the attention of scientists because of the intracellular reductive environment related to a high concentration of glutathione (GSH). In this context, we describe herein the development of a GSH-responsive delivery system based on poly(ethylene glycol)- (PEG-)…

INGENIERIA DE LA CONSTRUCCIONCell SurvivalIntracellular SpaceNanoparticleNanotechnologyAntineoplastic AgentsCONTROLLED-RELEASETRIGGERED RELEASEPolyethylene Glycolschemistry.chemical_compoundINORGANIC NANOPARTICLESQUIMICA ORGANICASYSTEMSPEG ratioQUIMICA ANALITICAElectrochemistrymedicinePOLYMER HYBRID NANOPARTICLESGLUTATHIONEBIOQUIMICA Y BIOLOGIA MOLECULARHumansGeneral Materials ScienceDoxorubicinSpectroscopyDrug CarriersENHANCED PERMEABILITYQUIMICA INORGANICASurfaces and InterfacesGlutathioneIN-VITROMesoporous silicaCondensed Matter PhysicsSilicon DioxideControlled releaseGUEST MOLECULESBioavailabilityDrug LiberationchemistryDoxorubicinDelayed-Action PreparationsDrug DesignNanoparticlesPhenazinesSUPPORTSEthylene glycolOxidation-ReductionPorositymedicine.drugHeLa Cells
researchProduct

CCDC 1819378: Experimental Crystal Structure Determination

2018

Related Article: Mónica Gorbe, Ana M. Costero, Félix Sancenón, Ramón Martínez-Máñez, Rafael Ballesteros-Cillero, Luis. E. Ochando, Katherine Chulvi, Raúl Gotor, Salvador Gil|2019|Dyes Pigm.|160|198|doi:10.1016/j.dyepig.2018.08.007

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters2-bromo-55-difluoro-1379-tetramethyl-10-phenyl-5H-4lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinineExperimental 3D Coordinates
researchProduct

CCDC 1819380: Experimental Crystal Structure Determination

2018

Related Article: Mónica Gorbe, Ana M. Costero, Félix Sancenón, Ramón Martínez-Máñez, Rafael Ballesteros-Cillero, Luis. E. Ochando, Katherine Chulvi, Raúl Gotor, Salvador Gil|2019|Dyes Pigm.|160|198|doi:10.1016/j.dyepig.2018.08.007

28-dibromo-55-difluoro-1379-tetramethyl-10-phenyl-5H-4lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinineSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1819379: Experimental Crystal Structure Determination

2018

Related Article: Mónica Gorbe, Ana M. Costero, Félix Sancenón, Ramón Martínez-Máñez, Rafael Ballesteros-Cillero, Luis. E. Ochando, Katherine Chulvi, Raúl Gotor, Salvador Gil|2019|Dyes Pigm.|160|198|doi:10.1016/j.dyepig.2018.08.007

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters55-difluoro-2-iodo-1379-tetramethyl-10-phenyl-5H-6lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinineExperimental 3D Coordinates
researchProduct

CCDC 1819381: Experimental Crystal Structure Determination

2018

Related Article: Mónica Gorbe, Ana M. Costero, Félix Sancenón, Ramón Martínez-Máñez, Rafael Ballesteros-Cillero, Luis. E. Ochando, Katherine Chulvi, Raúl Gotor, Salvador Gil|2019|Dyes Pigm.|160|198|doi:10.1016/j.dyepig.2018.08.007

Space GroupCrystallography55-difluoro-28-diiodo-1379-tetramethyl-10-phenyl-5H-6lambda55lambda5-dipyrrolo[12-c:2'1'-f][132]diazaborinineCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct